chr10-87933126-C-T

Variant summary

Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_000314.8(PTEN):​c.367C>T​(p.His123Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H123D) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

PTEN
NM_000314.8 missense

Scores

17
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 7.51
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 19 ACMG points.

PM1
In a hotspot region, there are 15 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_000314.8
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr10-87933126-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 428277.Status of the report is reviewed_by_expert_panel, 3 stars.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), PTEN. . Gene score misZ 3.4883 (greater than the threshold 3.09). Trascript score misZ 4.1129 (greater than threshold 3.09). GenCC has associacion of gene with Lhermitte-Duclos disease, Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, macrocephaly-autism syndrome, Cowden syndrome 1, Cowden disease, Proteus-like syndrome, leiomyosarcoma, activated PI3K-delta syndrome, PTEN hamartoma tumor syndrome, glioma susceptibility 2, renal cell carcinoma.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.992
PP5
Variant 10-87933126-C-T is Pathogenic according to our data. Variant chr10-87933126-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 189486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTENNM_000314.8 linkuse as main transcriptc.367C>T p.His123Tyr missense_variant 5/9 ENST00000371953.8
PTENNM_001304717.5 linkuse as main transcriptc.886C>T p.His296Tyr missense_variant 6/10
PTENNM_001304718.2 linkuse as main transcriptc.-384C>T 5_prime_UTR_variant 4/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTENENST00000371953.8 linkuse as main transcriptc.367C>T p.His123Tyr missense_variant 5/91 NM_000314.8 P1P60484-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cowden syndrome 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingMyriad Genetics, Inc.Sep 27, 2023This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 9256433, 10555148, 16619501, 21475810]. This variant is expected to disrupt protein structure [Myriad internal data]. -
Likely pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterMay 05, 2022- -
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoSep 14, 2023The PTEN c.367C>T (p.His123Tyr) variant has been reported in the published literature in an individual with breast cancer and a hematological malignancy (PMID: 26681312 (2015)). In a large-scale breast cancer association study, the variant was observed in an individual with breast cancer (PMID: 33471991 (2021), see also LOVD (http://databases.lovd.nl/shared/genes/PTEN)). Published functional studies suggest that this variant is detrimental to normal PTEN protein function (PMID: 21828076 (2011), 10555148 (1998), 9256433 (1997)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, this variant is classified as likely pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingGeneDxApr 03, 2023Published functional studies demonstrate a damaging effect: absent phosphatase activity (Myers et al., 1997; Lee et al., 1999; Rodriguez-Escudero et al., 2011); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in individual(s) with breast cancer (Evans et al., 2022); This variant is associated with the following publications: (PMID: 9256433, 16619501, 26681312, 10555148, 11448956, 21828076, 35426792, 19457929, 24475377, 32042934, 10772829) -
PTEN hamartoma tumor syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 19, 2018In summary, this variant is a rare missense change that disrupts PTEN function. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. The histidine 123 residue is known to be critical for PTEN protein function. Other missense substitutions at this position (His123Asp, His123Arg, His123Gln) also disrupt PTEN function and have been reported in individuals affected with Cowden syndrome (PMID: 11918710, 9259288, 21291452). This variant falls in the conserved P-loop in the active site of the PTEN protein (PMID: 10555148). Multiple experimental studies have shown that this variant abolishes PTEN kinase activity, and leads to cell proliferation, anchorage-independent growth, and loss of cell cycle progression inhibition (PMID: 21828076, 10555148, 16619501, 10772829, 9256433). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in the germline of individuals with a PTEN-related disease. ClinVar contains an entry for this variant (Variation ID: 189486). This sequence change replaces histidine with tyrosine at codon 123 of the PTEN protein (p.His123Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.58
D
BayesDel_noAF
Pathogenic
0.60
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.97
D
Eigen
Pathogenic
0.98
Eigen_PC
Pathogenic
0.88
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.89
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.89
D
MutationAssessor
Pathogenic
4.2
H
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.92
D
PROVEAN
Pathogenic
-5.8
D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.92
Loss of methylation at K125 (P = 0.0668);
MVP
0.99
MPC
2.5
ClinPred
1.0
D
GERP RS
5.2
Varity_R
0.99
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs786204931; hg19: chr10-89692883; COSMIC: COSV64290794; API